Quaker Chemical Corp. (KWR) 2025 Annual Report Summary
Business Context and Reporting Period
This summary covers the Form 10-K for Quaker Chemical Corporation (doing business as Quaker Houghton) for the fiscal year ended December 31, 2025. The Company is a global leader in industrial process fluids, serving steel, aluminum, automotive, aerospace, and metalworking industries across three segments: Americas, Europe/Middle East/Africa (EMEA), and Asia/Pacific. The reporting period reflects a year of strategic acquisitions, including Dipsol Chemicals, Natech, and CSI, alongside a significant non-cash goodwill impairment charge in the EMEA segment.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $1,888.6 million | $1,839.7 million |
| Gross Profit | $679.4 million | $686.0 million |
| Operating Income | $53.0 million | $194.7 million |
| Net Income (Loss) | ($2.5 million) | $116.6 million |
| Diluted EPS | ($0.14) | $6.51 |
| Adjusted EBITDA | $299.2 million | $310.9 million |
| Operating Cash Flow | $136.5 million | $204.6 million |
| Total Debt | $871.2 million | $708.3 million |
| Cash and Equivalents | $179.8 million | $188.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3% year-over-year, driven by a 4% contribution from acquisitions and 1% favorable foreign currency translation, partially offset by a 2% decrease in selling price and product mix. Organic sales volumes remained consistent.
- Profitability Decline: The Company reported a net loss of $2.5 million compared to net income of $116.6 million in 2024. This reversal was primarily due to an $88.8 million non-cash impairment charge to write down goodwill in the EMEA segment.
- Segment Performance:
- Americas: Net sales decreased 2% and operating earnings decreased 7% due to lower volumes and margins.
- EMEA: Net sales increased 2% (driven by acquisitions and currency), but operating earnings decreased 3% due to lower margins and higher SG&A.
- Asia/Pacific: Net sales increased 13% and operating earnings increased 1%, driven by strong organic volume growth and acquisitions.
- Acquisitions: The Company completed four acquisitions in 2025 (Dipsol, Natech, CSI, and Sutai), resulting in $164.2 million in net cash outflows for investing activities.
- Restructuring: Restructuring charges increased significantly to $35.1 million in 2025 from $6.5 million in 2024, related to headcount reductions and facility closures.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted progress on long-term strategic initiatives and new business wins, particularly in Asia/Pacific. However, they noted continued soft end-market conditions in the Americas and EMEA, exacerbated by tariff uncertainty. The Company expects to complete its global cost and optimization program by the end of 2026, targeting an additional $40 million in annualized cost savings.
Outlook: The Company believes its existing cash, operating cash flows, and available liquidity are sufficient to support operations, dividends, share repurchases, and capital expenditures for at least the next 12 months. No specific numerical guidance for 2026 was provided in this text.
Risks and Contingencies:
- Goodwill Impairment: The $88.8 million impairment in EMEA was triggered by lower projected financial performance and an increased cost of capital due to tariff uncertainty.
- Raw Material Costs: Earnings remain sensitive to volatile crude oil and natural gas prices, which impact the cost of mineral oils and oleochemicals.
- Geopolitical and Trade: Risks include tariffs, trade wars, and currency fluctuations, particularly involving the Euro, Brazilian real, and Chinese renminbi.
- Customer Concentration: The top five customers accounted for approximately 11% of consolidated net sales in 2025.
Investor Verification Checklist
- Impairment Details: Verify the specific assumptions used in the EMEA goodwill impairment test, particularly regarding the weighted average cost of capital (WACC) and projected EBITDA under current tariff scenarios.
- Acquisition Integration: Monitor the realization of synergies and revenue growth from the Dipsol, Natech, and CSI acquisitions, which contributed significantly to 2025 sales.
- Restructuring Progress: Track the execution of the global cost optimization program and the achievement of the targeted $40 million in additional annualized savings.
- Debt Covenants: Confirm continued compliance with the Credit Facility's consolidated net leverage ratio and interest coverage tests, especially given the increase in total debt to fund acquisitions.
- Raw Material Hedging: Assess the Company's ability to pass through increased raw material costs to customers without losing market share.